Please wait a minute...
文章检索
预防医学  2025, Vol. 37 Issue (9): 932-936    DOI: 10.19485/j.cnki.issn2096-5087.2025.09.014
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
2005—2023年温州市丙型病毒性肝炎流行特征分析
李君, 朱婷婷, 胡文雪
温州市疾病预防控制中心(温州市卫生监督所),浙江 温州 325001
Epidemiological characteristics of hepatitis C in Wenzhou City from 2005 to 2023
LI Jun, ZHU Tingting, HU Wenxue
Wenzhou Center for Disease Control and Prevention (Wenzhou Institute of Public Health Supervision), Wenzhou, Zhejiang 325001, China
全文: PDF(821 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析2005—2023年浙江省温州市丙型病毒性肝炎(丙肝)流行特征,为完善丙肝防控措施提供依据。方法 通过中国疾病预防控制信息系统监测报告管理系统收集2005—2023年温州市丙肝病例资料,采用描述性流行病学方法分析2005—2023年温州市丙肝不同性别、年龄发病情况;采用平均年度变化百分比(AAPC)分析丙肝报告发病率的变化趋势。结果 2005—2023年温州市报告丙肝病例15 707例,年均报告发病率为9.17/10万,报告发病率总体呈上升趋势(AAPC=2.401%,P<0.05)。职业以农民/民工、工人为主,5 382例占34.26%;其次为家政/家务及待业人员,3 045例占19.39%。鹿城区、平阳县和永嘉县丙肝年均报告发病率较高,分别为18.12/10万、13.53/10万和9.88/10万。男性10 816例,女性4 891例,男女比为2.21∶1;男性丙肝年均报告发病率为12.06/10万,高于女性的6.00/10万(P<0.05);男性丙肝报告发病率总体呈上升趋势(AAPC=3.011%,P<0.05),女性无明显变化趋势(AAPC=1.803%,P>0.05)。年龄以25~<55岁为主,12 659例占80.59%;0~<10岁、10~<20岁组丙肝报告发病率总体无明显变化趋势(AAPC=2.103%、1.126%,均P>0.05),20~<30岁、30~<40岁组呈下降趋势(AAPC=-13.160%、-7.159%,均P<0.05),40~<50岁、50~<60岁组呈上升趋势(AAPC=10.457%、11.831%,均P<0.05),≥60岁组无明显变化趋势(AAPC=2.867%,P>0.05)。结论 2005—2023年温州市丙肝报告发病率总体呈上升趋势,鹿城区、平阳县和永嘉县是高发地区,农民/民工、工人、男性和40~<60岁人群是防控重点人群。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
李君
朱婷婷
胡文雪
关键词 丙型病毒性肝炎发病率平均年度变化百分比    
AbstractObjective To analyze the epidemiological characteristics of hepatitis C in Wenzhou City, Zhejiang Province from 2005 to 2023, so as to provide the evidence for improving hepatitis C prevention and control measures. Methods The data of hepatitis C cases in Wenzhou City from 2005 to 2023 were collected from the China Disease Prevention and Control Information System. Descriptive epidemiological methods were used to describe the incidence of hepatitis C by gender and age in Wenzhou City from 2005 to 2023. Average annual percent change (AAPC) was used to analyze the trend of hepatitis C incidence. Results A total of 15 707 hepatitis C cases were reported in Wenzhou City from 2005 to 2023, with an average annual reported incidence of 9.17/105. The reported incidence showed an overall upward trend (AAPC=2.401%, P<0.05). In terms of occupation, farmers/migrant workers and workers accounted for 34.26% (5 382 cases), followed by domestic workers, those engaged in housework and unemployed people, accounting for 19.39% (3 045 cases). Lucheng District, Pingyang County, and Yongjia County had relatively high average annual reported incidences of hepatitis C, which were 18.12/105, 13.53/105 and 9.88/105, respectively. There were 10 816 males and 4 891 females, with a male-to-female ratio of 2.21∶1. The average annual reported incidence of hepatitis C in males was higher than in females (12.06/105 vs. 6.00/105, P<0.05). The reported incidence of hepatitis C in males showed an overall upward trend (AAPC=3.011%, P<0.05), but there was no significant change in females (AAPC=1.803%, P>0.05). The case was mainly aged 25-<55 years (12 659 cases, 80.59%). There was no significant change in incidence of hepatitis C in 0-<10 years old group and 10-<20 years old group (AAPC=2.103%, 1.126%, both P>0.05), while the incidence of hepatitis C in 20-<30 years old group and 30-<40 years old group showed downward trends (AAPC=>-13.160%, -7.159%, both P<0.05). There were upward trends in the 40-<50 years old group and 50-<60 years old group (AAPC=10.457%, 11.831%, both P<0.05), but no significant change in the ≥60 years old group (AAPC=2.867%, P>0.05). Conclusions The reported incidence of hepatitis C in Wenzhou City showed an overall upward trend from 2005 to 2023. Lucheng District, Pingyang County, and Yongjia County were high risk areas. Farmers/migrant workers, workers, males, and people aged 40-<60 years were the key population for prevention and control of hepatitis C.
Key wordshepatitis C    incidence    average annual percent change
收稿日期: 2025-04-07      修回日期: 2025-08-01      出版日期: 2025-09-10
中图分类号:  R512.63  
基金资助:温州市科技局项目(Y20220301)
作者简介: 李君,硕士,副主任医师,主要从事结核病、艾滋病和丙型病毒性肝炎防制工作,E-mail:16927145@qq.com
引用本文:   
李君, 朱婷婷, 胡文雪. 2005—2023年温州市丙型病毒性肝炎流行特征分析[J]. 预防医学, 2025, 37(9): 932-936.
LI Jun, ZHU Tingting, HU Wenxue. Epidemiological characteristics of hepatitis C in Wenzhou City from 2005 to 2023. Preventive Medicine, 2025, 37(9): 932-936.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.09.014      或      http://www.zjyfyxzz.com/CN/Y2025/V37/I9/932
[1] World Health Organization.Global hepatitisreport2024:action for access in low-and middle-income countries[EB/OL].[2025-08-01].https://www.who.int/publications/i/item/9789240091672.
[2] CUI F Q,BLACH S,MANZENGO MINGIEDI C M,et al.Global reporting of progress towards elimination of hepatitis B and hepatitis C[J].Lancet Gastroenterol Hepatol,2023,8(4):332-342.
[3] 刘小畅,赵婷,赵志梅,等.中国居民病毒性肝炎流行趋势分析[J].预防医学,2018,30(5):433-437.
LIU X C,ZHAO T,ZHAO Z M,et al.Incidence and trends of viral hepatitis in China[J].China Prev Med J,2018,30(5):433-437.(in Chinese)
[4] 李健,庞琳,王晓春,等.中国丙型肝炎防治进展与展望[J].中国艾滋病性病,2022,28(7):761-765.
LI J,PANG L,WANG X C,et al.Progress and prospect of hepatitis C prevention and treatment in China[J].Chin J AIDS STD,2022,28(7):761-765.(in Chinese)
[5] 周欣,程伟,潘晓红,等.2004—2021年浙江省报告丙型肝炎病例特征分析[J].中国艾滋病性病,2023,29(3):334-337.
ZHOU X,CHENG W,PAN X H,et al.Epidemiological characteristics of hepatitis C in Zhejiang Province from 2004 to 2021[J].Chin J AIDS STD,2023,29(3):334-337.(in Chinese)
[6] 中华人民共和国国家卫生和计划生育委员会.WS 213—2018丙型肝炎诊断[J].中国病毒病杂志,2018,8(4):248-251.
National Health and Family Planning Commission of The People's Republic of China.WS 213—2018 diagnosis for hepatitis C[J].Chin J Viral Dis,2018,8(4):248-251.(in Chinese)
[7] 国家卫生健康委员会. 2022中国卫生健康统计年鉴[EB/OL].[2025-08-01].https://www.nhc.gov.cn/mohwsbwstjxxzx/tjtjnj/202305/49beded3bd984669bfe9089c6f231cf5.shtml.
[8] 朱珂,王憓,唐慧玲,等.2005—2023年浙江省金华市丙型肝炎流行病学特征[J].上海预防医学,2025,37(2):135-139.
ZHU K,WANG H,TANG H L,et al.Epidemiological characteristics of patients with hepatitis C in Jinhua City,Zhejiang Province from 2005 to 2023[J].Shanghai J Prev Med,2025,37(2):135-139.(in Chinese)
[9] 刘锐,蔺茂文,江鸿,等.2008—2022年荆州市丙型病毒性肝炎发病的年龄、时期、队列趋势分析[J].预防医学,2023,35(10):871-876.
LIU R,LIN M W,JIANG H,et al.Trends in age-,period-and cohort-specific incidence of hepatitis C in Jingzhou City from 2008 to 2022[J].China Prev Med J,2023,35(10):871-876.(in Chinese)
[10] 李文军,李慧,杨景元,等.2008—2022年赤峰市丙型病毒性肝炎发病的年龄、时期、队列趋势分析[J].预防医学,2024,36(6):514-517,522.
LI W J,LI H,YANG J Y,et al.Trends in age-,period-and cohort-specific incidence of hepatitis C in Chifeng City from 2008 to 2022[J].China Prev Med J,2024,36(6):514-517,522.(in Chinese)
[11] 郭艳,苏兴芳,张小斌,等.云南省2018—2022年丙型肝炎时空聚集性分析[J].皮肤病与性病,2024,46(5):315-318.
GUO Y,SU X F,ZHANG X B,et al.Spatial-temporal clustering analysis of hepatitis C in Yunnan Province from 2018 to 2022[J].Dermatol Venereol,2024,46(5):315-318.(in Chinese)
[12] 庞秋艳,董五星.2014—2023年河南省焦作市丙型肝炎流行特征及预测分析[J].现代疾病预防控制,2024,35(12):902-906.
PANG Q Y,DONG W X.Epidemiological characteristics and prediction of hepatitis C in Jiaozuo,Henan(2014 to 2023)[J].Mod Dis Control Prev,2024,35(12):902-906.(in Chinese)
[13] 于兰,惠珊,佟雪,等.黑龙江省2011—2020年丙型病毒性肝炎病例报告分析[J].哈尔滨医药,2021,41(4):3-5.
YU L,HUI S,TONG X,et al.Case report analysis of hepatitis C virus in Heilongjiang Province from 2011-2020[J].Harbin Med J,2021,41(4):3-5.(in Chinese)
[14] 丁旭,任达飞,高前荣,等.2006—2020年贵州省铜仁市丙型病毒性肝炎流行特征分析[J].现代预防医学,2022,49(6):1003-1005,1015.
DING X,REN D F,GAO Q R,et al.Epidemiological characteristics of hepatitis C in Tongren from 2006 to 2020[J].Mod Prev Med,2022,49(6):1003-1005,1015.(in Chinese)
[15] 陈楚莹,陈秀云,王曼,等.2006—2019年中山市丙型病毒性肝炎报告发病率的年龄-时期-队列分析[J].中华疾病控制杂志,2021,25(7):775-778.
CHEN C Y,CHEN X Y,WANG M,et al.An age-period-cohort study for reported incidence of hepatitis C in Zhongshan City,from 2006 to 2019[J].Chin J Dis Control Prev,2021,25(7):775-778.(in Chinese)
[1] 李玉荣, 王冬飞, 高媛媛, 蒋园园, 林君英, 肖段段. 2010—2024年萧山区结直肠癌发病趋势分析[J]. 预防医学, 2025, 37(9): 927-931,936.
[2] 胡晓强, 刘艳, 周思凡, 张子喆, 王雨达, 沈建勇. 2014—2023年湖州市流行性感冒流行特征分析[J]. 预防医学, 2025, 37(9): 959-962.
[3] 李克, 庞志峰, 吴晓虹, 王诚, 何瑶, 唐慧玲. 2007—2024年金华市钩端螺旋体病流行特征分析[J]. 预防医学, 2025, 37(8): 818-821.
[4] 冷雪, 傅淑琴, 舒纪为, 谭启龙, 李科峰. 舟山市带状疱疹首诊病例特征分析[J]. 预防医学, 2025, 37(7): 701-704.
[5] 朱颖, 郑添. 2013—2023年嘉善县居民期望寿命变化[J]. 预防医学, 2025, 37(6): 598-602.
[6] 董沙沙, 项云飞. 2014—2023年余姚市原发性肝癌死亡与疾病负担分析[J]. 预防医学, 2025, 37(6): 603-607.
[7] 丁哲渊, 杨研, 傅天颖, 鲁琴宝, 王心怡, 吴昊澄, 刘魁, 林君芬, 吴晨. 2024年浙江省法定传染病疫情分析[J]. 预防医学, 2025, 37(5): 433-438,442.
[8] 任露露, 顾嘉昌, 闵艺璇, 张思晨, 乔健健, 肖月, 胡静. 2016—2023年宜兴市脑卒中发病趋势分析[J]. 预防医学, 2025, 37(5): 498-502.
[9] 李慧君, 叶振淼, 樊丽辉, 郑宇航, 谢轶敏, 姜雪霞, 高豪俊, 张默涵, 罗永园. 2015—2023年温州市老年人跌倒死亡趋势与减寿分析[J]. 预防医学, 2025, 37(5): 460-464.
[10] 周沁易, 马涛, 赵跃媛, 王恒学, 吴小清, 丁松宁, 苏晶晶. 2004—2022年南京市法定传染病发病趋势分析[J]. 预防医学, 2025, 37(5): 476-480.
[11] 白峻竹, 比里克孜汉·阿西木, 游姝萌, 阿米乃·艾比, 金雅静, 徐元勇, 温亮, 张文义, 买买提江·吾布力艾山. 2016—2022年和田地区乙型病毒性肝炎和丙型病毒性肝炎流行特征分析[J]. 预防医学, 2025, 37(4): 404-407,412.
[12] 王洪岩, 任飞林, 刘小琦, 金玫华, 吴振乾. 2009—2023年湖州市HIV/AIDS病例新发现率趋势分析[J]. 预防医学, 2025, 37(4): 395-399.
[13] 叶振淼, 樊丽辉, 姜雪霞, 郑宇航, 张默涵, 罗永园, 谢轶敏, 李慧君, 金茜. 2014—2023年温州市胃癌死亡及减寿趋势分析[J]. 预防医学, 2025, 37(3): 267-271.
[14] 张小乔, 张筱碟, 赵振希, 谢鹏留, 代敏. LSTM、SARIMA和SARIMAX模型预测手足口病发病率的效果比较[J]. 预防医学, 2025, 37(3): 280-284,287.
[15] 沈敏, 郁智慧, 朱爱韬. 1992—2021年中国慢性阻塞性肺疾病发病和死亡的年龄-时期-队列分析[J]. 预防医学, 2025, 37(2): 113-117.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed